Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Change in Receivables (2021 - 2025)

Historic Change in Receivables for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to $1.6 million.

  • Molecular Partners Ag's Change in Receivables fell 34.19% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339978.6, marking a year-over-year increase of 6548.33%. This contributed to the annual value of -$394435.5 for FY2024, which is 6249.98% up from last year.
  • Latest data reveals that Molecular Partners Ag reported Change in Receivables of $1.6 million as of Q3 2025, which was down 34.19% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Change in Receivables registered a high of $26.2 million during Q4 2022, and its lowest value of -$25.3 million during Q4 2021.
  • Its 5-year average for Change in Receivables is -$21623.5, with a median of -$1834.1 in 2025.
  • Over the last 5 years, Molecular Partners Ag's Change in Receivables had its largest YoY gain of 65040.05% in 2022, and its largest YoY loss of 54698.33% in 2022.
  • Molecular Partners Ag's Change in Receivables (Quarter) stood at -$25.3 million in 2021, then surged by 203.36% to $26.2 million in 2022, then tumbled by 104.01% to -$1.1 million in 2023, then soared by 62.46% to -$394569.3 in 2024, then surged by 506.86% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, -$1.5 million for Q2 2025, and -$1834.1 during Q1 2025.